|
Volumn 19, Issue 17-19, 2001, Pages 2576-2582
|
Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: First randomized phase III trials show promise
|
Author keywords
Autologous; Colon cancer vaccine; Immunotherapy
|
Indexed keywords
BCG VACCINE;
IMMUNOLOGICAL ADJUVANT;
ONCOVAX;
TUMOR CELL VACCINE;
CANCER ADJUVANT THERAPY;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLON CARCINOMA;
COLON RESECTION;
CONFERENCE PAPER;
DRUG EFFICACY;
HUMAN;
META ANALYSIS;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TUMOR CELL;
AUTOANTIGENS;
CANCER VACCINES;
COLONIC NEOPLASMS;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
HUMANS;
HYPERSENSITIVITY, DELAYED;
IMMUNOTHERAPY;
PROSPECTIVE STUDIES;
|
EID: 0035925638
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(00)00485-0 Document Type: Conference Paper |
Times cited : (115)
|
References (12)
|